PAMELA BURIAN: Open Payments
NPI 1942210893 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 28 payments from 7 companies in 2025. Trend: 2023 $761 · 2024 $889 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 15 | $317 |
| Merck Sharp & Dohme LLC | 7 | $195 |
| Gilead Sciences, Inc. | 2 | $139 |
| Theratechnologies Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Exact Sciences Corporation | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
Products named: PIFELTRO, CABENUVA, DOVATO, APRETUDE, EGRIFTA, SHINGRIX, RUKOBIA, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
